Valiant Laboratories

122.58
+1.96
(1.62%)
Market Cap (₹ Cr.)
₹526
52 Week High
214.95
Book Value
₹55
52 Week Low
100.20
PE Ratio
PB Ratio
2.22
PE for Sector
38.75
PB for Sector
4.65
ROE
0.13 %
ROCE
-0.22 %
Dividend Yield
0.00 %
EPS
₹0.00
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
-43.40 %
Net Income Growth
-98.90 %
Cash Flow Change
-96.63 %
ROE
-57.57 %
ROCE
-101.80 %
EBITDA Margin (Avg.)
-94.37 %

Financial Results

Quarterly Financials
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
84
89
72
92
54
63
42
33
21
Expenses
79
77
61
81
48
61
47
35
21
EBITDA
4
12
11
10
6
2
-5
-2
-0
Operating Profit %
5 %
12 %
14 %
10 %
7 %
-2 %
-16 %
-15 %
-13 %
Depreciation
0
0
0
0
0
0
0
1
1
Interest
0
0
0
0
0
0
0
0
0
Profit Before Tax
4
12
10
10
6
1
-5
-3
-1
Tax
1
3
3
2
1
1
-1
-2
0
Net Profit
3
9
8
8
4
1
-4
-1
-1
EPS in ₹
1.65
5.32
4.70
2.41
1.31
0.24
-0.81
-0.32
-0.23

Balance Sheet

Balance Sheet
2021
2022
2023
2024
Total Assets
106
182
213
325
Fixed Assets
20
22
30
32
Current Assets
86
157
182
209
Capital Work in Progress
0
1
0
0
Investments
0
0
34
119
Other Assets
87
158
149
174
Total Liabilities
18
110
112
88
Current Liabilities
16
49
51
26
Non Current Liabilities
2
61
62
61
Total Equity
89
71
100
237
Reserve & Surplus
78
55
68
193
Share Capital
11
16
33
43

Cash Flow

Cash Flow
2021
2022
2023
2024
Net Cash Flow
4
-4
0
2
Investing Activities
-17
-12
-21
-183
Operating Activities
9
2
23
49
Financing Activities
11
6
-2
136

Share Holding

% Holding
Sept 2023
Oct 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
FIIs
8.64 %
8.64 %
7.08 %
3.48 %
1.89 %
DIIs
3.89 %
3.89 %
0.47 %
0.03 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
12.53 %
12.53 %
17.51 %
21.55 %
23.17 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,919.95 4,62,183.91 43.83 49,887.17 12.06 9,648 42.62 69.11
1,664.85 1,33,571.58 30.05 26,520.66 14.17 4,155 17.77 58.51
6,749.10 1,12,773.77 20.26 28,905.40 12.36 5,578 -0.90 52.91
1,080.35 1,07,501.01 25.79 19,831.50 13.82 3,831 30.78 42.63
2,578.95 1,01,024.42 51.48 10,615.63 19.57 1,942 9.89 57.29
2,194.40 99,904.51 44.14 20,141.50 19.94 1,936 77.69 52.16
1,438.30 85,599.77 23.86 29,559.25 17.55 3,169 61.17 35.32
6,151.25 72,467.15 33.71 12,978.42 9.84 1,811 91.18 54.09
1,666.95 47,227.01 - 12,653.09 6.58 -1,831 96.52 50.20
370.65 43,587.78 27.93 15,621.20 35.25 1,298 478.78 51.92

Corporate Action

Technical Indicators

RSI(14)
Neutral
51.53
ATR(14)
Less Volatile
5.71
STOCH(9,6)
Neutral
31.83
STOCH RSI(14)
Neutral
40.96
MACD(12,26)
Bearish
-0.12
ADX(14)
Weak Trend
15.40
UO(9)
Bearish
42.75
ROC(12)
Downtrend But Slowing Down
-3.88
WillR(14)
Neutral
-58.86